Please assess the completion status of the following clinical trial:

Trial Title: Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Persistent thin lining \< 6mm on \>1 cycle in previous IVF or FET cycle OR moderate-to-severe Asherman's syndrome~Exclusion Criteria:~* Age \<18 years old or \>43 years old,~* Pregnancy,~* Diagnosis of cancer,~* Hb \<11 g/dL, platelets \<150,000/mm3,~* Anticoagulation,~* NSAIDs in the 10 days before procedure~* Any significant comorbidity or psychiatric disorder that would compromise patient safety or compliance, interfere with consent, study participation, follow up, or interpretation of study results.~* Incision in the uterus: myomectomy; cesarean section

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 43 Years
- Healthy Volunteers: t

Study Arms:
- PRP intrauterine infusion (Type: EXPERIMENTAL): Intrauterine infusion of platelet rich plasma in combination with standard treatment, in patients with Asherman's Syndrome or thin uterine lining in frozen embryo transfer cycles
- Control group with standard treatment only (Type: NO_INTERVENTION): Patients with Asherman's Syndrome or thin uterine lining in frozen embryo transfer cycles undergoing standard treatment protocols

Based on this trial design, predict the completion outcome and termination type (if applicable).